search
Back to results

Supported Treadmill Ambulation Training (STAT) for Patients Diagnosed With Amyotrophic Lateral Aclerosis

Primary Purpose

Amyotrophic Lateral Sclerosis, Motor Neuron Disease, Lou Gehrig's Disease

Status
Completed
Phase
Phase 1
Locations
United States
Study Type
Interventional
Intervention
Treadmill Exercise
Sponsored by
Wake Forest University Health Sciences
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Amyotrophic Lateral Sclerosis focused on measuring Exercise for Amyotrophic lateral sclerosis

Eligibility Criteria

25 Years - 75 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Clinically probable or definite diagnosis of ALS/MND
  • Able to stand independently and ambulate for six minutes with their assistive devices
  • Able to complete the 25 foot walk in less than 1 minute
  • Vital Capacity of over 65% predicted
  • 25 to 75 years of age
  • Not a pregnant woman
  • Able to provide informed consent and to comply with training and assessment procedures

Exclusion Criteria:

  • Unstable angina or severe left main coronary disease
  • End-stage congestive heart failure
  • Severe valvular heart disease
  • Malignant or unstable arrhythmias
  • Elevated resting blood pressure (systolic, 200mmHg; diastolic, 110mmHg)
  • Large or expanding aortic aneurysm
  • Known cerebral aneurysm or recent intracranial bleed
  • Uncontrolled or end-stage systemic disease
  • Acute retinal hemorrhage or recent ophthalmologic surgery
  • Acute or unstable musculoskeletal injury

Sites / Locations

  • Carolinas ALS Clinical Resarch Center

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

supported treadmill ambulation training

Arm Description

Outcomes

Primary Outcome Measures

Twenty Five Foot Walk Test (25FWT)
The Six-Minute Walk Test (6MWT)
Fatigue severity scale (FSS)

Secondary Outcome Measures

Muscle strength
ALS functional rating scale (ALSFRS-R)
Vital Capacity
Beck Depression Inventory (BDI)

Full Information

First Posted
August 10, 2009
Last Updated
April 19, 2022
Sponsor
Wake Forest University Health Sciences
search

1. Study Identification

Unique Protocol Identification Number
NCT00956488
Brief Title
Supported Treadmill Ambulation Training (STAT) for Patients Diagnosed With Amyotrophic Lateral Aclerosis
Official Title
Supported Treadmill Ambulation Training (STAT) for Patients Diagnosed With Amyotrophic Lateral Aclerosis
Study Type
Interventional

2. Study Status

Record Verification Date
July 2013
Overall Recruitment Status
Completed
Study Start Date
September 2008 (undefined)
Primary Completion Date
September 2010 (Actual)
Study Completion Date
September 2010 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Wake Forest University Health Sciences

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The purpose of this study is to find out if supervised exercise training using a treadmill with partial weight support is safe and has an impact on gait and function of persons with Amyotrophic lateral sclerosis.
Detailed Description
Twenty ALS patients who are independent in their transfer with assistive devise such as walker, cane, or AFO will be offered the opportunity to participate in this study. 20 subjects will be enrolled at Carolinas ALS/Neuromuscular Center at the Carolinas HealthCare System. Eligible subjects will return for 26 sessions, each lasting between 1-2 hours. At Session 1 (4 weeks pre-treatment), assessments of muscle strength, spasticity, gait, and balance will be performed, which will take between 30-60 minutes. At Sessions 2-25, patients will do supported treadmill ambulation training at a very low speed 3 times a week for 6 weeks under the supervision of the physical therapist. Each session will have 30 minutes of direct ambulation with the suspension system and treadmill over a 60 minute period of time. Additionally, at sessions 13 and 26 (4 and 8 weeks post-treatment), the assessments of muscle strength, spasticity, gait, and balance will be repeated. Needle EMG to assess denervation potential will be performed at base line and at the conclusion of the study. The study will last a total of 26 weeks for each patient.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Amyotrophic Lateral Sclerosis, Motor Neuron Disease, Lou Gehrig's Disease
Keywords
Exercise for Amyotrophic lateral sclerosis

7. Study Design

Primary Purpose
Prevention
Study Phase
Phase 1, Phase 2
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
9 (Actual)

8. Arms, Groups, and Interventions

Arm Title
supported treadmill ambulation training
Arm Type
Experimental
Intervention Type
Behavioral
Intervention Name(s)
Treadmill Exercise
Intervention Description
The intervention will consist of 30 minutes of exercise, performed 3 times per week for 8 weeks (24 sessions). Patient will walk on a treadmill with up to 40% of their body weight supported by a body weight support system with an overhead harness. The training session duration will be 60 minutes consisting of six intervals of 5 minutes exercise, interspersed with 6 intervals of 5 minutes rest to avoid overwork weakness and fatigue. Five minute exercise intervals should be sufficient for patients to reach a steady state. Patients will build up their endurance to this training level at their own pace as tolerated. Walking speed will be determined as tolerated by each patient. Exercise intensity will be guided by each patient's own perception of exertion, but not to exceed level 12-13 (mild to moderate) on the modified Borg perceived exertion scale, and by oxygen saturation (Sa O2) ≥ 90% monitor by handheld pulse Oximeter.
Primary Outcome Measure Information:
Title
Twenty Five Foot Walk Test (25FWT)
Time Frame
baseline, after 4 weaks and 8 weaks post training
Title
The Six-Minute Walk Test (6MWT)
Time Frame
baseline, after 4 weaks and 8 weaks post training
Title
Fatigue severity scale (FSS)
Time Frame
baseline, after 4 weaks and 8 weaks post training
Secondary Outcome Measure Information:
Title
Muscle strength
Time Frame
baseline, after 4 weaks and 8 weaks post training
Title
ALS functional rating scale (ALSFRS-R)
Time Frame
baseline, after 4 weaks and 8 weaks post training
Title
Vital Capacity
Time Frame
baseline, after 4 weaks and 8 weaks post training
Title
Beck Depression Inventory (BDI)
Time Frame
baseline, after 4 weaks and 8 weaks post training

10. Eligibility

Sex
All
Minimum Age & Unit of Time
25 Years
Maximum Age & Unit of Time
75 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Clinically probable or definite diagnosis of ALS/MND Able to stand independently and ambulate for six minutes with their assistive devices Able to complete the 25 foot walk in less than 1 minute Vital Capacity of over 65% predicted 25 to 75 years of age Not a pregnant woman Able to provide informed consent and to comply with training and assessment procedures Exclusion Criteria: Unstable angina or severe left main coronary disease End-stage congestive heart failure Severe valvular heart disease Malignant or unstable arrhythmias Elevated resting blood pressure (systolic, 200mmHg; diastolic, 110mmHg) Large or expanding aortic aneurysm Known cerebral aneurysm or recent intracranial bleed Uncontrolled or end-stage systemic disease Acute retinal hemorrhage or recent ophthalmologic surgery Acute or unstable musculoskeletal injury
Facility Information:
Facility Name
Carolinas ALS Clinical Resarch Center
City
Charlotte
State/Province
North Carolina
ZIP/Postal Code
28207
Country
United States

12. IPD Sharing Statement

Learn more about this trial

Supported Treadmill Ambulation Training (STAT) for Patients Diagnosed With Amyotrophic Lateral Aclerosis

We'll reach out to this number within 24 hrs